子车谷波
Lv12
76 积分
2021-08-08 加入
-
In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes
16小时前
已完结
-
The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease
8天前
已完结
-
Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management—A Systematic Review
8天前
已完结
-
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
10天前
已完结
-
Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
11天前
已完结
-
CS12192: A novel selective and potent JAK3 inhibitor mitigates acute graft-versus-host disease in bone marrow transplantation
12天前
已完结
-
Discovery of DWP213388, a Potent ITK and BTK Selective Dual Inhibitor with Excellent Efficacy and Safety, for Treating Gvhd
12天前
已关闭
-
Combinatorial inhibition of Tec kinases BTK and ITK is beneficial in ameliorating murine sclerodermatous chronic graft versus host disease
13天前
已完结
-
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system
13天前
已完结
-
Vitiligo: advances in pathophysiology research and treatment development
15天前
已完结